IMMUCELL CORP DE (ICCC)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Product sales | 6,444,880 | 8,067,174 | 6,011,573 | 5,472,890 |
| Costs of goods sold | 3,626,956 | 4,713,202 | 4,428,019 | 4,242,404 |
| Gross margin | 2,817,924 | 3,353,972 | 1,583,554 | 1,230,486 |
| Sales and marketing expenses | 696,086 | 856,658 | 844,045 | 984,957 |
| Product development expenses | 831,858 | 756,847 | 786,136 | 1,030,502 |
| Administrative expenses | 720,418 | 622,843 | 528,267 | 601,634 |
| Operating expenses | 2,248,362 | 2,236,348 | 2,158,448 | 2,617,093 |
| Net operating income (loss) | 569,562 | 1,117,624 | -574,894 | -1,386,607 |
| Other (expenses) income, net | -65,778 | 331,263 | -125,456 | - |
| Other nonoperating income (expense) | - | - | - | -143,679 |
| Income (loss) before income taxes | 503,784 | 1,448,887 | -700,350 | -1,530,286 |
| Income tax expense | 1,904 | 1,904 | 1,340 | 1,340 |
| Net income (loss) | 501,880 | 1,446,983 | -701,690 | -1,531,626 |
| Basic net income (loss) per share (in dollars per share) | 0.06 | 0.16 | -0.09 | -0.2 |
| Basic weighted average common shares outstanding (in shares) | 9,031,282 | 8,980,602 | 8,164,423 | 7,810,037 |
| Diluted net income (loss) per share (in dollars per share) | 0.06 | 0.16 | -0.09 | -0.2 |
| Weighted average common shares outstanding - diluted | 9,031,282 | 8,980,602 | 8,164,423 | 7,810,037 |